Liu Z - Search Results

1

An MMAE-loaded PDL1 active targeting nanomedicine for the precision treatment of colon cancer.

Zhang Z, Zhang H, Cui L, Wang X, Wang D, Liu Z, Zhang X, Tang Z. Zhang Z, et al. Among authors: liu z. Biomater Sci. 2023 Jul 25;11(15):5195-5204. doi: 10.1039/d3bm00664f. Biomater Sci. 2023. PMID: 37337707

2

Solid Tumor Therapy Using a Cannon and Pawn Combination Strategy.

Song W, Tang Z, Zhang D, Wen X, Lv S, Liu Z, Deng M, Chen X. Song W, et al. Among authors: liu z. Theranostics. 2016 Apr 28;6(7):1023-30. doi: 10.7150/thno.14741. eCollection 2016. Theranostics. 2016. PMID: 27217835 Free PMC article.

3

An eximious and affordable GSH stimulus-responsive poly(α-lipoic acid) nanocarrier bonding combretastatin A4 for tumor therapy.

Liu Z , Shen N , Tang Z , Zhang D , Ma L , Yang C , Chen X . Liu Z , et al. Biomater Sci. 2019 Jun 25;7(7):2803-2811. doi: 10.1039/c9bm00002j. Biomater Sci. 2019. PMID: 31062006

4

Correction: An eximious and affordable GSH stimulus-responsive poly(α-lipoic acid) nanocarrier bonding combretastatin A4 for tumor therapy.

Liu Z, Shen N, Tang Z, Zhang D, Ma L, Yang C, Chen X. Liu Z, et al. Biomater Sci. 2020 May 21;8(10):2977. doi: 10.1039/d0bm90037k. Epub 2020 Apr 23. Biomater Sci. 2020. PMID: 32322862

5

Synergistic Therapy for Cervical Cancer by Codelivery of Cisplatin and JQ1 Inhibiting Plk1-Mutant Trp53 Axis.

Wang Y, Shen N, Li S, Yu H, Wang Y, Liu Z, Han L, Tang Z. Wang Y, et al. Among authors: liu z. Nano Lett. 2021 Mar 24;21(6):2412-2421. doi: 10.1021/acs.nanolett.0c04402. Epub 2021 Mar 11. Nano Lett. 2021. PMID: 33705152

6

Destruction of tumor vasculature by vascular disrupting agents in overcoming the limitation of EPR effect.

Liu Z, Zhang Y, Shen N, Sun J, Tang Z, Chen X. Liu Z, et al. Adv Drug Deliv Rev. 2022 Apr;183:114138. doi: 10.1016/j.addr.2022.114138. Epub 2022 Feb 7. Adv Drug Deliv Rev. 2022. PMID: 35143895 Review.

7

Formula optimization and in vivo study of poly(L-glutamic acid)-g-methoxy poly(ethylene glycol)/combretastatin A4/BLZ945 nanoparticles for cancer therapy.

Huang Y, Yang C, Lv J, Zhang Y, Wang K, Ma L, Liu Z, Yu H, Li M, Tang Z. Huang Y, et al. Among authors: liu z. Int J Pharm. 2023 Apr 5;636:122849. doi: 10.1016/j.ijpharm.2023.122849. Epub 2023 Mar 17. Int J Pharm. 2023. PMID: 36933582

8

Azide-Masked Resiquimod Activated by Hypoxia for Selective Tumor Therapy.

Sun J, Liu Z, Yao H, Zhang H, Zheng M, Shen N, Cheng J, Tang Z, Chen X. Sun J, et al. Among authors: liu z. Adv Mater. 2023 Jul;35(29):e2207733. doi: 10.1002/adma.202207733. Epub 2023 Jun 6. Adv Mater. 2023. PMID: 37086177

9

Organic-Solvent-Free "Lego-Like" Modular Preparation of Fab-Nondestructive Antibody-Drug Conjugates with Ultrahigh Drug-to-Antibody Ratio.

Liu Z, Zhang H, Sun J, Zheng M, Cui L, Zhang Y, Cheng J, Tang Z, Chen X. Liu Z, et al. Adv Mater. 2023 Nov;35(46):e2300377. doi: 10.1002/adma.202300377. Epub 2023 Oct 15. Adv Mater. 2023. PMID: 37532247

10

Preparation of an Ultrahigh-DAR PDL1 monoclonal antibody-polymeric-SN38 conjugate for precise colon cancer therapy.

Zhang H, Sun J, Zhang Y, Zhang Z, Wang X, Liu Z, Zhang X, Tang Z, Chen X. Zhang H, et al. Among authors: liu z. Biomaterials. 2023 Oct;301:122285. doi: 10.1016/j.biomaterials.2023.122285. Epub 2023 Aug 17. Biomaterials. 2023. PMID: 37619265

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

90,623 results

Search Page

Filters